コンパニオン診断の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Companion Diagnostic Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D005-00227 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、コンパニオン診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。コンパニオン診断の種類別市場規模（アッセイキット、試薬）、用途別市場規模（製薬・バイオ製薬会社、研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Thermo Fisher Scientific、Illumina、Agilent Technologies、Roche、Danaher、Novartis、Qiagen、Myriad Genetics、Sysmex ・地域別グローバル市場分析 2015年-2020年 ・コンパニオン診断の北米市場（アメリカ、カナダ、メキシコ） ・コンパニオン診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・コンパニオン診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・コンパニオン診断の南米市場（ブラジル、アルゼンチン） ・コンパニオン診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アッセイキット、試薬 ・用途別分析：製薬・バイオ製薬会社、研究所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Companion Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 19.4% in the forecast period of 2020 to 2025 and will expected to reach USD 18430 million by 2025, from USD 9075.3 million in 2019.

The Companion Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Companion Diagnostic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Companion Diagnostic market has been segmented into:
Assay Kits
Reagents

By Application, Companion Diagnostic has been segmented into:
Pharmaceutical & Biopharmaceutical Companies
Laboratories
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Companion Diagnostic market presented in the report. This section sheds light on the sales growth of different regional and country-level Companion Diagnostic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Companion Diagnostic market.

The report offers in-depth assessment of the growth and other aspects of the Companion Diagnostic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Companion Diagnostic Market Share Analysis
Companion Diagnostic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Companion Diagnostic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Companion Diagnostic sales, revenue and market share for each player covered in this report.

The major players covered in Companion Diagnostic are:
Abbott Laboratories
Thermo Fisher Scientific
Illumina
Agilent Technologies
Roche
Danaher
Novartis
Qiagen
Myriad Genetics
Sysmex

レポート目次

---

Table of Contents

1 Companion Diagnostic Market Overview
1.1 Product Overview and Scope of Companion Diagnostic
1.2 Classification of Companion Diagnostic by Type
1.2.1 Global Companion Diagnostic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Companion Diagnostic Revenue Market Share by Type in 2019
1.2.3 Assay Kits
1.2.4 Reagents
1.3 Global Companion Diagnostic Market by Application
1.3.1 Overview: Global Companion Diagnostic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical & Biopharmaceutical Companies
1.3.3 Laboratories
1.3.4 Other
1.4 Global Companion Diagnostic Market by Regions
1.4.1 Global Companion Diagnostic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Companion Diagnostic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Companion Diagnostic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Companion Diagnostic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Companion Diagnostic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Companion Diagnostic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Companion Diagnostic Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Thermo Fisher Scientific SWOT Analysis
2.2.4 Thermo Fisher Scientific Product and Services
2.2.5 Thermo Fisher Scientific Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Illumina SWOT Analysis
2.3.4 Illumina Product and Services
2.3.5 Illumina Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Agilent Technologies SWOT Analysis
2.4.4 Agilent Technologies Product and Services
2.4.5 Agilent Technologies Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.6 Danaher
2.6.1 Danaher Details
2.6.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Danaher SWOT Analysis
2.6.4 Danaher Product and Services
2.6.5 Danaher Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis SWOT Analysis
2.7.4 Novartis Product and Services
2.7.5 Novartis Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.8 Qiagen
2.8.1 Qiagen Details
2.8.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Qiagen SWOT Analysis
2.8.4 Qiagen Product and Services
2.8.5 Qiagen Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.9 Myriad Genetics
2.9.1 Myriad Genetics Details
2.9.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Myriad Genetics SWOT Analysis
2.9.4 Myriad Genetics Product and Services
2.9.5 Myriad Genetics Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sysmex
2.10.1 Sysmex Details
2.10.2 Sysmex Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sysmex SWOT Analysis
2.10.4 Sysmex Product and Services
2.10.5 Sysmex Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Companion Diagnostic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Companion Diagnostic Players Market Share
3.2.2 Top 10 Companion Diagnostic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Companion Diagnostic Revenue and Market Share by Regions
4.2 North America Companion Diagnostic Revenue and Growth Rate (2015-2020)
4.3 Europe Companion Diagnostic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Companion Diagnostic Revenue and Growth Rate (2015-2020)
4.5 South America Companion Diagnostic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Companion Diagnostic Revenue and Growth Rate (2015-2020)
5 North America Companion Diagnostic Revenue by Countries
5.1 North America Companion Diagnostic Revenue by Countries (2015-2020)
5.2 USA Companion Diagnostic Revenue and Growth Rate (2015-2020)
5.3 Canada Companion Diagnostic Revenue and Growth Rate (2015-2020)
5.4 Mexico Companion Diagnostic Revenue and Growth Rate (2015-2020)
6 Europe Companion Diagnostic Revenue by Countries
6.1 Europe Companion Diagnostic Revenue by Countries (2015-2020)
6.2 Germany Companion Diagnostic Revenue and Growth Rate (2015-2020)
6.3 UK Companion Diagnostic Revenue and Growth Rate (2015-2020)
6.4 France Companion Diagnostic Revenue and Growth Rate (2015-2020)
6.5 Russia Companion Diagnostic Revenue and Growth Rate (2015-2020)
6.6 Italy Companion Diagnostic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Companion Diagnostic Revenue by Countries
7.1 Asia-Pacific Companion Diagnostic Revenue by Countries (2015-2020)
7.2 China Companion Diagnostic Revenue and Growth Rate (2015-2020)
7.3 Japan Companion Diagnostic Revenue and Growth Rate (2015-2020)
7.4 Korea Companion Diagnostic Revenue and Growth Rate (2015-2020)
7.5 India Companion Diagnostic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Companion Diagnostic Revenue and Growth Rate (2015-2020)
8 South America Companion Diagnostic Revenue by Countries
8.1 South America Companion Diagnostic Revenue by Countries (2015-2020)
8.2 Brazil Companion Diagnostic Revenue and Growth Rate (2015-2020)
8.3 Argentina Companion Diagnostic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Companion Diagnostic by Countries
9.1 Middle East & Africa Companion Diagnostic Revenue by Countries (2015-2020)
9.2 Saudi Arabia Companion Diagnostic Revenue and Growth Rate (2015-2020)
9.3 UAE Companion Diagnostic Revenue and Growth Rate (2015-2020)
9.4 Egypt Companion Diagnostic Revenue and Growth Rate (2015-2020)
9.5 South Africa Companion Diagnostic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Companion Diagnostic Revenue and Market Share by Type (2015-2020)
10.2 Global Companion Diagnostic Market Forecast by Type (2019-2024)
10.3 Assay Kits Revenue Growth Rate (2015-2025)
10.4 Reagents Revenue Growth Rate (2015-2025)
11 Global Companion Diagnostic Market Segment by Application
11.1 Global Companion Diagnostic Revenue Market Share by Application (2015-2020)
11.2 Companion Diagnostic Market Forecast by Application (2019-2024)
11.3 Pharmaceutical & Biopharmaceutical Companies Revenue Growth (2015-2020)
11.4 Laboratories Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Companion Diagnostic Market Size Forecast (2021-2025)
12.1 Global Companion Diagnostic Market Size Forecast (2021-2025)
12.2 Global Companion Diagnostic Market Forecast by Regions (2021-2025)
12.3 North America Companion Diagnostic Revenue Market Forecast (2021-2025)
12.4 Europe Companion Diagnostic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Companion Diagnostic Revenue Market Forecast (2021-2025)
12.6 South America Companion Diagnostic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Companion Diagnostic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Companion Diagnostic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Companion Diagnostic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Companion Diagnostic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Companion Diagnostic Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Companion Diagnostic Major Business
Table 7. Abbott Laboratories Companion Diagnostic Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Companion Diagnostic Product and Solutions
Table 10. Abbott Laboratories Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 12. Thermo Fisher Scientific Companion Diagnostic Major Business
Table 13. Thermo Fisher Scientific Companion Diagnostic Total Revenue (USD Million) (2018-2019)
Table 14. Thermo Fisher Scientific SWOT Analysis
Table 15. Thermo Fisher Scientific Companion Diagnostic Product and Solutions
Table 16. Thermo Fisher Scientific Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Illumina Corporate Information, Location and Competitors
Table 18. Illumina Companion Diagnostic Major Business
Table 19. Illumina Companion Diagnostic Total Revenue (USD Million) (2017-2018)
Table 20. Illumina SWOT Analysis
Table 21. Illumina Companion Diagnostic Product and Solutions
Table 22. Illumina Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Agilent Technologies Corporate Information, Location and Competitors
Table 24. Agilent Technologies Companion Diagnostic Major Business
Table 25. Agilent Technologies Companion Diagnostic Total Revenue (USD Million) (2017-2018)
Table 26. Agilent Technologies SWOT Analysis
Table 27. Agilent Technologies Companion Diagnostic Product and Solutions
Table 28. Agilent Technologies Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Roche Corporate Information, Location and Competitors
Table 30. Roche Companion Diagnostic Major Business
Table 31. Roche Companion Diagnostic Total Revenue (USD Million) (2017-2018)
Table 32. Roche SWOT Analysis
Table 33. Roche Companion Diagnostic Product and Solutions
Table 34. Roche Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Danaher Corporate Information, Location and Competitors
Table 36. Danaher Companion Diagnostic Major Business
Table 37. Danaher Companion Diagnostic Total Revenue (USD Million) (2017-2018)
Table 38. Danaher SWOT Analysis
Table 39. Danaher Companion Diagnostic Product and Solutions
Table 40. Danaher Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Novartis Corporate Information, Location and Competitors
Table 42. Novartis Companion Diagnostic Major Business
Table 43. Novartis Companion Diagnostic Total Revenue (USD Million) (2017-2018)
Table 44. Novartis SWOT Analysis
Table 45. Novartis Companion Diagnostic Product and Solutions
Table 46. Novartis Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Qiagen Corporate Information, Location and Competitors
Table 48. Qiagen Companion Diagnostic Major Business
Table 49. Qiagen Companion Diagnostic Total Revenue (USD Million) (2017-2018)
Table 50. Qiagen SWOT Analysis
Table 51. Qiagen Companion Diagnostic Product and Solutions
Table 52. Qiagen Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Myriad Genetics Corporate Information, Location and Competitors
Table 54. Myriad Genetics Companion Diagnostic Major Business
Table 55. Myriad Genetics Companion Diagnostic Total Revenue (USD Million) (2017-2018)
Table 56. Myriad Genetics SWOT Analysis
Table 57. Myriad Genetics Companion Diagnostic Product and Solutions
Table 58. Myriad Genetics Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Sysmex Corporate Information, Location and Competitors
Table 60. Sysmex Companion Diagnostic Major Business
Table 61. Sysmex Companion Diagnostic Total Revenue (USD Million) (2017-2018)
Table 62. Sysmex SWOT Analysis
Table 63. Sysmex Companion Diagnostic Product and Solutions
Table 64. Sysmex Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Companion Diagnostic Revenue (Million USD) by Players (2015-2020)
Table 66. Global Companion Diagnostic Revenue Share by Players (2015-2020)
Table 67. Global Companion Diagnostic Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Companion Diagnostic Revenue Market Share by Regions (2015-2020)
Table 69. North America Companion Diagnostic Revenue by Countries (2015-2020)
Table 70. North America Companion Diagnostic Revenue Market Share by Countries (2015-2020)
Table 71. Europe Companion Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Companion Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Companion Diagnostic Revenue by Countries (2015-2020)
Table 74. South America Companion Diagnostic Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Companion Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Companion Diagnostic Revenue Market Share by Countries (2015-2020)
Table 77. Global Companion Diagnostic Revenue (Million USD) by Type (2015-2020)
Table 78. Global Companion Diagnostic Revenue Share by Type (2015-2020)
Table 79. Global Companion Diagnostic Revenue Forecast by Type (2021-2025)
Table 80. Global Companion Diagnostic Revenue by Application (2015-2020)
Table 81. Global Companion Diagnostic Revenue Share by Application (2015-2020)
Table 82. Global Companion Diagnostic Revenue Forecast by Application (2021-2025)
Table 83. Global Companion Diagnostic Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Companion Diagnostic Picture
Figure 2. Global Companion Diagnostic Revenue Market Share by Type in 2019
Figure 3. Assay Kits Picture
Figure 4. Reagents Picture
Figure 5. Companion Diagnostic Revenue Market Share by Application in 2019
Figure 6. Pharmaceutical & Biopharmaceutical Companies Picture
Figure 7. Laboratories Picture
Figure 8. Other Picture
Figure 9. Global Companion Diagnostic Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Companion Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Companion Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Companion Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Companion Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Companion Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Companion Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Companion Diagnostic Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Companion Diagnostic Revenue Market Share in 2019
Figure 18. Global Top 10 Players Companion Diagnostic Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Companion Diagnostic Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Companion Diagnostic Revenue Market Share by Regions (2015-2020)
Figure 22. Global Companion Diagnostic Revenue Market Share by Regions in 2018
Figure 23. North America Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 24. Europe Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 26. South America Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 28. North America Companion Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 29. North America Companion Diagnostic Revenue Market Share by Countries in 2019
Figure 30. USA Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 31. Canada Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 33. Europe Companion Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Companion Diagnostic Revenue Market Share by Countries in 2019
Figure 35. Germany Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 36. UK Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 37. France Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 38. Russia Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 39. Italy Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Companion Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Companion Diagnostic Revenue Market Share by Countries in 2019
Figure 42. China Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 43. Japan Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 44. Korea Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 45. India Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 47. South America Companion Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 48. South America Companion Diagnostic Revenue Market Share by Countries in 2019
Figure 49. Brazil Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Companion Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Companion Diagnostic Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 54. UAE Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Companion Diagnostic Revenue and Growth Rate (2015-2020)
Figure 57. Global Companion Diagnostic Revenue Share by Type (2015-2020)
Figure 58. Global Companion Diagnostic Revenue Share by Type in 2019
Figure 59. Global Companion Diagnostic Market Share Forecast by Type (2021-2025)
Figure 60. Global Assay Kits Revenue Growth Rate (2015-2020)
Figure 61. Global Reagents Revenue Growth Rate (2015-2020)
Figure 62. Global Companion Diagnostic Revenue Share by Application (2015-2020)
Figure 63. Global Companion Diagnostic Revenue Share by Application in 2019
Figure 64. Global Companion Diagnostic Market Share Forecast by Application (2021-2025)
Figure 65. Global Pharmaceutical & Biopharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 66. Global Laboratories Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Companion Diagnostic Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Companion Diagnostic Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Companion Diagnostic Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Companion Diagnostic Revenue Market Forecast (2021-2025)
Figure 72. Europe Companion Diagnostic Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Companion Diagnostic Revenue Market Forecast (2021-2025)
Figure 74. South America Companion Diagnostic Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Companion Diagnostic Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---